Structural neuroimaging in Alzheimer's disease: Do white matter hyperintensities matter?

Dialogues in Clinical Neuroscience

Volumn 11, Issue 2, 2009, Pages 181-190

  Brickman, Adam M ^a   Muraskin, Jordan ^a   Zimmerman, Molly E ^b  

^a Columbia University ^*  (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Beta amyloid; MRI; White matter hyperintensity

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; BRAIN ISCHEMIA; BRAIN REGION; CEREBROVASCULAR DISEASE; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; WHITE MATTER; AGING; ARTICLE; BRAIN; COGNITIVE DEFECT; MYELINATED NERVE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; THREE DIMENSIONAL IMAGING;

AGING; ALZHEIMER DISEASE; BRAIN; COGNITION DISORDERS; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; NERVE FIBERS, MYELINATED;

EID: 67650831263     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Elkins JS, O'Meara ES, Longstreth WT, Jr, Carlson MC, Manolio TA, Johnston SC. Stroke risk factors and loss of high cognitive function. Neurology. 2004;63:793-799.
2. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension. 1998;31:780-786. (Pubitemid 28108576)
3. Kivipelto M, Helkala EL, Hanninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology. 2001;56:1683-1689. (Pubitemid 32574567)
4. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ (Clinical research ed). 2001;322:1447-1451. (Pubitemid 32575406)
5. Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001;56:42-48. (Pubitemid 32059650)
6. Swan GE, DeCarli C, Miller BL, Reed T, Wolf PA, Jack LM, Carmelli D. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology. 1998;51:986-993. (Pubitemid 28473389)
7. Brickman AM, Buchsbaum MS, Shihabuddin L, et al. Age-associated change in orbital, cingulate, and dorsolateral frontal lobe gray and white matter volume [abstract]. J Int Neuropsych Soc. 2005;11(suppl 1):176.
8. Brickman AM, Habeck C, Ramos MA, Scarmeas N, Stern Y. A forward application of age associated gray and white matter networks. Hum Brain Map. 2008;29:1139-1146.
9. Brickman AM, Habeck C, Zarahn E, Flynn J, Stern Y. Structural MRI covariance patterns associated with normal aging and neuropsychological functioning. Neurobiol Aging. 2007;28:284-295. (Pubitemid 44894636)
10. Brickman AM, Zimmerman ME, Paul RH, et al. Regional white matter and neuropsychological functioning across the adult lifespan. Biol Psychiatry. 2006;60:444-453.
11. Zimmerman ME, Brickman AM, Paul RH, et al. The relationship between frontal gray matter volume and cognition varies across the healthy adult lifespan. Am J Geriatr Psychiatry. 2006;14:823-833.
12. Brickman AM, Buchsbaum MS. Alzheimer's disease and normal aging: Neurostructures. In: Byrne JH, ed. Learning and Memory: a Comprehensive Reference. Vol 3. New York, NY: Elsevier; 2008:601-621.
13. Gunning-Dixon FM, Brickman AM, Cheng JC, Alexopoulos GS. Aging of cerebral white matter: a review of MRI findings. Int J Geriatr Psychiatry. 2009;24:109-117.
14. DeCarli C, Massaro J, Harvey D, et al. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol Aging. 2005;26:491-510. (Pubitemid 40093933)
15. Pfefferbaum A, Mathalon DH, Sullivan EV, Rawles JM, Zipursky RB, Lim KO. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol. 1994;51:874-887. (Pubitemid 24286042)
16. Coffey CE, Wilkinson WE, Parashos IA, et al. Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology. 1992;42:527-536.
17. Scheltens P, Barkhof F, Valk J, et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain. 1992;115:735-748.
18. Admiraal-Behloul F, Olofesen H, Van den Heuvel DM, Schmitz N, Reiber JH, Van Buchem MA. Fully automated lobe delineation for regional white matter lesion load quantification in a large scale study. Proc Int Soc Magn Reson Med. 2004:138.
19. Pantoni L, Poggesi A, Inzitari D. The relation between white-matter lesions and cognition. Curr Opin Neurol. 2007;20:390-397.
20. Yoshita M, Fletcher E, Harvey D, et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology. 2006;67:2192-2198.
21. Moody DM, Bell MA, Challa VR. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. Am J Neuroradiol. 1990;11:431-439.
22. Nelson MD, Jr., Gonzalez-Gomez I, Gilles FH. Dyke Award. The search for human telencephalic ventriculofugal arteries. Am J Neuroradiol. 1991;12:215-222.
23. Awad IA, Spetzler RF, Hodak JA, Awad CA, Carey R. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke. 1986;17:1084-1089.
24. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Carmelli D. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol. 2001;58:643-647.
25. Inzitari D, Diaz F, Fox A, et al. Vascular risk factors and leuko-araiosis. Arch Neurol. 1987;44:42-47.
26. Longstreth WT, Jr, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke. 1996;27:1274-1282.
27. Streifler JY, Eliasziw M, Benavente OR, Hachinski VC, Fox AJ, Barnett HJ. Lack of relationship between leukoaraiosis and carotid artery disease. The North American Symptomatic Carotid Endarterectomy Trial. Arch Neurol. 1995;52:21-24.
28. Rowbotham GF, Little E. A new concept of the circulation and the circulations of the brain, the discovery of surface arteriovenous shunts. Br J Surg. 1965;52:539-542.
29. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997;28:652-659.
30. De Reuck J. The human periventricular arterial blood supply and the anatomy of cerebral infarctions. Eur Neurol. 1971;5:321-334.
31. Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683-1689. (Pubitemid 23307935)
32. Thomas AJ, O'Brien JT, Davis S, et al. Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry. 2002;59:785-792. (Pubitemid 35001143)
33. Englund E. Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord. 1998;9(suppl 1):6-12. (Pubitemid 28325636)
34. Udaka F, Sawada H, Kameyama M. White matter lesions and dementia: MRI-pathological correlation. Ann N Y Acad Sci. 2002;977:411-415. (Pubitemid 35418183)
35. Brickman AM, Zahra A, Muraskin J, et al. Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psych Res: Neuroimaging. 2009;172:117-120.
36. Holland CM, Smith EE, Csapo I, et al. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke. 2008;39:1127-1133.
37. Brickman AM, Schupf N, Manly JJ, et al. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol. 2008;65:1053-1061.
38. Brickman AM, Siedlecki KL, Muraskin J, et al. White matter hyperintensities and cognition: testing the reserve hypothesis (abstract). J Int Neuropsych Soc. 2009;15(suppl S1):53.
39. Gunning-Dixon FM, Raz N. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology. 2000;14:224-232. (Pubitemid 30687601)
40. Oosterman JM, Sergeant JA, Weinstein HC, Scherder EJ. Timed executive functions and white matter in aging with and without cardiovascular risk factors. Rev Neurosci. 2004;15:439-462.
41. Albert M. Neuropsychological and neurophysiological changes in healthy adult humans across the age range. Neurobiol Aging. 1993;14:623-625. (Pubitemid 23347898)
42. Royall DR, Lauterbach EC, Cummings JL, et al. Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci. 2002;14:377-405.
43. Oosterman JM, van Harten B, Weinstein HC, Scheltens P, Sergeant JA, Scherder EJ. White matter hyperintensities and working memory: an explorative study. Neuropsychol Dev Cogn. 2008;15:384-399. (Pubitemid 351550993)
44. Paul RH, Gunstad J, Poppas A, et al. Neuroimaging and cardiac correlates of cognitive function among patients with cardiac disease. Cerebrovasc Dis (Basel, Switzerland). 2005;20:129-133. (Pubitemid 41160213)
45. Nordahl CW, Ranganath C, Yonelinas AP, et al. White matter changes compromise prefrontal cortex function in healthy elderly individuals. J Cogn Neurosci. 2006;18:418-429.
46. Kramer JH, Mungas D, Reed BR, et al. Longitudinal MRI and cognitive change in healthy elderly. Neuropsychology. 2007;21:412-418. (Pubitemid 47445212)
47. Longstreth WT, Jr, Arnold AM, Beauchamp NJ, Jr, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke. 2005;36:56-61.
48. van den Heuvel DM, ten Dam VH, de Craen AJ, et al. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. J Neurol Neurosurg Psychiatry. 2006;77:149-153.
49. Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging. 2000;21:321-330. (Pubitemid 30387091)
50. Meyer JS, Kawamura J, Terayama Y. White matter lesions in the elderly. J Neur Sci. 1992;110:1-7.
51. Rezek DL, Morris JC, Fulling KH, Gado MH. Periventricular white matter lucencies in senile dementia of the Alzheimer type and in normal aging. Neurology. 1987;37:1365-1368.
52. Leys D, Pruvo JP, Parent M, et al. Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? J Neurol Neurosurg Psychiatry. 1991;54:46-50.
53. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239-259.
54. Luchsinger JA, Brickman AM, Reitz C, et al. Subclinical cerebrovascular disease in mild cognitive impairment. Neurology. In press.
55. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol. 2004;61:1531-1534. (Pubitemid 39350263)
56. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222. (Pubitemid 36359297)
57. Wolf H, Ecke GM, Bettin S, Dietrich J, Gertz HJ. Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int J Geriatr Psychiatry. 2000;15:803-812.
58. Smith EE, Egorova S, Blacker D. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol. 2008;65:94-100.
59. Brickman AM, Honig LS, Scarmeas N, et al. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch Neurol. 2008;65:1202-1208.
60. van der Flier WM, Barkhof F, Scheltens P. Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRI. Ann N Y Acad Sci. 2007;1097:215-224. (Pubitemid 47084890)
61. van der Flier WM, Middelkoop HA, Weverling-Rijnsburger AW, et al. Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD. Neurology. 2004;62:1862-1864. (Pubitemid 38661753)
62. DeCarli C, Mungas D, Harvey D, Reed B, Weiner M, Chui H, Jagust W. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology. 2004;63:220-227. (Pubitemid 38971118)
63. Small SA, Duff K. Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron. 2008;60:534-542.
64. Schupf N, Tang MX, Fukuyama H, et al. Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc Natl Acad Sci U S A. 2008;105:14052-14057.
65. Roher AE, Kuo YM, Esh C, et al. Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol Med (Cambridge, Mass). 2003;9:112-122. (Pubitemid 36819967)
66. Weller RO, Cohen NR, Nicoll JA. Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy. Panminerva Med. 2004;46:239-251.
67. Niwa K, Carlson GA, Iadecola C. Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice. J Cereb Blood Flow Metab. 2000;20:1659-1668.
68. Preston SD, Steart PV, Wilkinson A, Nicoll JA, Weller RO. Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol Appl Neurobiol. 2003;29:106-117. (Pubitemid 36408329)
69. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. beta-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature. 1996;380:168-171. (Pubitemid 26085884)
70. Roher AE, Weiss N, Kokjohn TA, et al. Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. Biochemistry. 2002;41:11080-11090. (Pubitemid 35034009)
71. Gurol ME, Irizarry MC, Smith EE, et al. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology. 2006;66:23-29.
72. van Dijk EJ, Prins ND, Vermeer SE, et al. Plasma amyloid beta, apolipoprotein E, lacunar infarcts, and white matter lesions. Ann Neurol. 2004;55:570-575.
73. Maia LF, Vasconcelos C, Seixas S, Magalhaes R, Correia M. Lobar brain hemorrhages and white matter changes: Clinical, radiological and laboratorial profiles. Cerebrovasc Dis (Basel, Switzerland). 2006;22:155-161. (Pubitemid 44114458)
74. Chen YW, Gurol ME, Rosand J, Viswanathan A, Rakich SM, Groover TR, Greenberg SM, Smith EE. Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology. 2006;67:83-87. (Pubitemid 44305466)
75. Pettersen JA, Sathiyamoorthy G, Gao FQ, et al. Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch Neurol. 2008;65:790-795. (Pubitemid 351831457)
76. Lopresti BJ, Klunk WE, Mathis CA, et al. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med. 2005;46:1959-1972.
77. Price JC, Klunk WE, Lopresti BJ, et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab. 2005;25:1528-1547.
78. Mintun MA, Larossa GN, Sheline YI, et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology. 2006;67:446-452.
79. Fagan AM, Mintun MA, Mach RH, et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol. 2006;59:512-519.
80. Greenberg SM, Grabowski T, Gurol ME, et al. Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol. 2008;64:587-591.
81. Johnson KA, Gregas M, Becker JA, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol. 2007;62:229-234. (Pubitemid 47525398)
82. Petrovitch H, Ross GW, Steinhorn SC, et al. AD lesions and infarcts in demented and non-demented Japanese-American men. Ann Neurol. 2005;57:98-103. (Pubitemid 40053320)
83. Riekse RG, Leverenz JB, McCormick W, et al. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study. J Am Geriatr Soc. 2004;52:1442-1448. (Pubitemid 39209590)
84. Rockwood K, Davis H, MacKnight C, et al. The Consortium to Investigate Vascular Impairment of Cognition: methods and first findings. Can J Neurol Sci. 2003;30:237-243. (Pubitemid 37064520)
85. Luchsinger JA, Honig LS, Tang MX, Devanand DP. Depressive symptoms, vascular risk factors, and Alzheimer's disease. Int J Geriatr Psychiatry. 2008;23:922-928.
86. Hachinski V. Shifts in thinking about dementia. JAMA. 2008;300:2172-2173.